What We Do
Gene therapy is advancing quickly, but families are often left with too much information and too little clarity. Melody Lab’s role is to translate and connect—without crossing into medical guidance.
Our Boundary
-
We do not provide medical advice, diagnosis, or treatment recommendations
-
We do not interpret personal medical records
-
We do not enroll patients in clinical trials
-
We do provide education, source curation, and community learning
Gene Therapy, In A Nutshell
What it is: Approaches that aim to address disease by changing gene function—by adding, reducing, or editing genetic activity.
What it isn’t: A guaranteed cure. It is complex science with real limits, risks, and unknowns.
Can Gene Therapy Treat This Mutation?
Gene therapy feasibility depends on biology, technology, and current scientific limits—not hope alone.
This section provides high-level, non-clinical scientific assessments of whether existing gene therapy approaches are theoretically feasible for specific disease-associated genes based on current technology.
This is not medical advice, not a treatment recommendation, and not a prediction of clinical success.
What This Assessment Is — and Is Not
✅ What this section provides
-
Gene-level scientific feasibility analysis
-
Technology-based reasoning (delivery, gene size, biology)
-
A snapshot of current-state science, not future promises
❌ What this section does not do
-
Diagnose disease
-
Evaluate individual mutations or patients
-
Recommend therapies or clinical trials
-
Predict timelines or outcomes
How We Assess Feasibility (Science-Only)
Each gene is evaluated by at least two volunteer gene therapy experts using publicly known scientific criteria, including:
-
Gene size (AAV compatibility)
-
Mechanism of disease (loss vs gain of function)
-
Expression sensitivity (dose tolerance)
-
Target tissue accessibility
-
Cell-type specificity
-
Preclinical or clinical precedent
-
Delivery challenges
-
Safety considerations (high-level)
No patient data is reviewed.
Feasibility Score (Non-Clinical)
Each gene is assigned a Scientific Feasibility Score reflecting how well current gene therapy technologies align with the biology of that gene.
Score | Meaning |
|---|---|
🟢 High | Biology and delivery are generally compatible with current gene therapy approaches |
🟠 Low | Major scientific barriers remain with current technology |
🔴 Very Low / Not Feasible (Currently) | Known limitations make gene therapy impractical at this time |
🟡 Moderate | Significant challenges exist, but plausible strategies are under investigation |